Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Sulphadoxine-Pyrimethamine and Amodiaquine in Ghanaian Pregnant Women
This study has been completed.
Study NCT00131703 Information provided by Gates Malaria Partnership
First Received: August 18, 2005 Last Updated: December 1, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
Pregnancy
More general conditions related to this trial
Coccidiosis
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Amodiaquine
Sulphadoxine-pyrimethamine
Chloroquine
Additional drug interventions recognized in this trial
Chloroquine diphosphate
Pyrimethamine
Sulfadoxine
Sulfadoxine-pyrimethamine
More general drug interventions related to this trial
Amebicides
Analgesics
Analgesics, Non-Narcotic
Anthelmintics
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antimalarials
Antinematodal Agents
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Enzyme Inhibitors
Filaricides
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Gates Malaria Partnership
London School of Hygiene and Tropical Medicine
Ministry of Health, Ghana
Back to top of Main Content
